Sidley Austin
)
Sidley’s Global Life Sciences practice takes an integrated, multidisciplinary approach to serving animal health clients worldwide, addressing their full spectrum of legal needs with the goal of enhancing animal health and wellbeing, as well as securing high-quality sources of protein. We draw on our deep industry expertise and understanding of regulators to develop sophisticated strategies for engaging with key authorities, such as the FDA, European Medicines Agency (EMA), European Commission, the UK Veterinary Medicines Directorate (VMD), and China’s National Medical Products Administration (NMPA). We also maintain strong relationships with leading industry bodies, including HealthforAnimals, AnimalHealthEurope, and the National Office of Animal Health (NOAH).
Our highly credible animal health practice is led by Dr. Chris Boyle, a qualified veterinary surgeon and recognised thought leader in the sector, enabling Sidley to support clients in areas such as: promotion of veterinary medicines, commercialisation including discounts and rebate schemes, antitrust/competition law, product recalls, suspension of marketing authorisations by regulators, cross-border and online retail of veterinary medicines, off-label use and compounding, supplementary protection certificates, and regulatory classification of products including borderline issues (e.g. between veterinary medicines, supplements, feeds, medical devices, and pesticides). Our comprehensive practice includes transactional expertise led by Robert Darwin, a prominent M&A, Private Equity, and life sciences lawyer. Robert advises global life sciences corporations and investors on a range of deals, including acquisitions, strategic collaborations, and private equity buyouts. His close collaboration with our regulatory team streamlines due diligence and addresses key regulatory issues for prospective buyers.
Sidley’s Animal Health Legal Forum (AHLF), hosted by our Global Animal Health Practice and Dr Chris Boyle, is a unique network that connects in-house animal health lawyers, regulatory affairs and compliance professionals, and investors. It serves as a platform for discussing the latest industry developments, sharing best practices, and fostering connections within the animal health community.
Our highly credible animal health practice is led by Dr. Chris Boyle, a qualified veterinary surgeon and recognised thought leader in the sector, enabling Sidley to support clients in areas such as: promotion of veterinary medicines, commercialisation including discounts and rebate schemes, antitrust/competition law, product recalls, suspension of marketing authorisations by regulators, cross-border and online retail of veterinary medicines, off-label use and compounding, supplementary protection certificates, and regulatory classification of products including borderline issues (e.g. between veterinary medicines, supplements, feeds, medical devices, and pesticides). Our comprehensive practice includes transactional expertise led by Robert Darwin, a prominent M&A, Private Equity, and life sciences lawyer. Robert advises global life sciences corporations and investors on a range of deals, including acquisitions, strategic collaborations, and private equity buyouts. His close collaboration with our regulatory team streamlines due diligence and addresses key regulatory issues for prospective buyers.
Sidley’s Animal Health Legal Forum (AHLF), hosted by our Global Animal Health Practice and Dr Chris Boyle, is a unique network that connects in-house animal health lawyers, regulatory affairs and compliance professionals, and investors. It serves as a platform for discussing the latest industry developments, sharing best practices, and fostering connections within the animal health community.